NCT07842029 · RECRUITING
Evaluation of Blood-Based Biomarkers and Remote Cognitive Assessment for Dementia Triage (SANDBOX)
This study tests whether a blood test for Alzheimer's-related proteins, an APOE genetic test, and a recorded speech and memory assessment can help NHS Memory Clinics diagnose dementia faster. It's not testing a treatment, just whether these tools improve and speed up diagnosis. No phase specified, but this is an evaluation study, not a drug trial.
Eligibility criteria
Inclusion Criteria: * The participant is willing and able to provide informed consent for participation in the study, or if unable to consent, a consultee (nearest of kin or holder of Power of Attorney) is available to make a declaration. * Eligibility for recruitment in Scotland is restricted to participants who are able to provide informed consent themselves; participants requiring consultee consent will not be recruited in Scotland. * Male or female, aged 50 years or older. * The participant is currently on a waiting list for a participating Memory Clinic. * The participant lives within traveling distance to a study site. * The participant agrees to complete all study procedures, including genetic testing. Exclusion Criteria: * The participant may not enter the study if any of the following criteria apply: * The participant has known or anticipated challenges with venous blood sampling. * The participant is not fluent in English. * The participant has a historical diagnosis of dementia.
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2026-09-25